课题基金 / 基金详情

Degradable nanocapsules for thromboprophylaxis and treatment of acute thrombosis

Degradable nanocapsules for thromboprophylaxis and treatment of acute thrombosis
可降解纳米胶囊用于血栓预防和治疗急性血栓形成
批准号:
nhmrc : GNT1138361
负责人:
A/Pr Christoph Hagemeyer
金额:
$115.84万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 --

项目摘要

项目成果

A/Pr Christoph Hagemeyer的其他基金

相似基金

相关文献

中文摘要
翻译
在澳大利亚,脂肪在血管中积聚的后果,如心脏病发作和脑梗死,是导致死亡的主要原因。凝块抑制剂已被证明对心脏病发作、腿部或肺部的凝块以及脑梗死患者有益。然而,目前可用的药物在有效性和安全性方面有很大的局限性。该项目的目的是开发有可能显著改善这两种情况的新药。
英文摘要
The consequences of fat build up in vessels such as heart attacks and brain infarcts are the major cause of death in Australia. Clot busters have been proven to be beneficial for patients with heart attacks, clots in the legs or lungs and brain infarcts. However, the currently available drugs have major limitations in efficacy and in safety. The aim of this project is to develop novel drugs that have the potential to improve both significantly.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Smart targeted nanoparticles for diagnosis and therapy
  • 批准号:
    nhmrc : GNT1154270
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $72.42万
  • 财政年份:
    2019
  • 负责人:
    A/Pr Christoph Hagemeyer
  • 依托单位:
Degradable nanocapsules for thromboprophylaxis and treatment of acute thrombosis
  • 批准号:
    nhmrc : 1138361
  • 项目类别:
    Project Grants
  • 资助金额:
    $78.33万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Christoph Hagemeyer
  • 依托单位:
Molecular imaging and therapy of cardiac fibrosis in atrial fibrillation and heart failure
  • 批准号:
    nhmrc : 1120129
  • 项目类别:
    Project Grants
  • 资助金额:
    $68.96万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Christoph Hagemeyer
  • 依托单位:
Molecular imaging and therapy of cardiac fibrosis in atrial fibrillation and heart failure
  • 批准号:
    nhmrc : GNT1120129
  • 项目类别:
    Project Grants
  • 资助金额:
    $102.17万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Christoph Hagemeyer
  • 依托单位:
海外基金